What is the most recent FDA action on file for Emcure Pharmaceuticals Limited?

May 15, 2026. Argus HQ ingests new FDA enforcement records daily.

Is this FDA enforcement data for Emcure Pharmaceuticals Limited official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Emcure Pharmaceuticals Limited had?

Argus HQ has recorded 1 FDA events for Emcure Pharmaceuticals Limited: 0 warning letters, 0 recalls, 0 approvals, and 1 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Emcure Pharmaceuticals Limited?

The most recent FDA event Argus HQ has on file for Emcure Pharmaceuticals Limited is dated 2026-05-15, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

FDA Enforcement History: Emcure Pharmaceuticals Limited

At a glance: Argus HQ has recorded 1 FDA events for Emcure Pharmaceuticals Limited: 0 warning letters, 0 recalls, 0 approvals, and 1 inspection 483 observations. These events span from 2026-05-15 to 2026-05-15. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

FDA action counts

Total FDA actions	1
Warning letters	0
Recalls	0
Approval records	0
Form 483 inspection citations	1
Most recent action	May 15, 2026

Enforcement history

On 2026-05-15, Argus HQ recorded an FDA Form 483 inspection citation for Emcure Pharmaceuticals Limited, rated "high" severity in Argus HQ's classification: Emcure Pharmaceuticals Limited -- FDA 483: 1 observation (2026-05-15). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Emcure Pharmaceuticals Limited has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

What is the most recent FDA action on file for Emcure Pharmaceuticals Limited?: May 15, 2026. Argus HQ ingests new FDA enforcement records daily.
Is this FDA enforcement data for Emcure Pharmaceuticals Limited official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
How many FDA actions has Emcure Pharmaceuticals Limited had?: Argus HQ has recorded 1 FDA events for Emcure Pharmaceuticals Limited: 0 warning letters, 0 recalls, 0 approvals, and 1 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
What is the most recent FDA action against Emcure Pharmaceuticals Limited?: The most recent FDA event Argus HQ has on file for Emcure Pharmaceuticals Limited is dated 2026-05-15, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Emcure Pharmaceuticals Limited -- FDA 483: 1 observation (2026-05-15) →

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: May 15, 2026

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). FDA Enforcement History: Emcure Pharmaceuticals Limited. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/emcure-pharmaceuticals-limited

MLA

"FDA Enforcement History: Emcure Pharmaceuticals Limited." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/emcure-pharmaceuticals-limited.

Chicago

Argus HQ Research. "FDA Enforcement History: Emcure Pharmaceuticals Limited." Digital Empire Holdings LLC. Accessed August 6, 2026. https://argushq.ai/company/emcure-pharmaceuticals-limited.

BibTeX

@misc{argushq_argushq_ai_company_emcure_pharmaceuticals_limited_2026,
  title = {FDA Enforcement History: Emcure Pharmaceuticals Limited},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/company/emcure-pharmaceuticals-limited},
  note = {Accessed: August 6, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗